nodes	percent_of_prediction	percent_of_DWPC	metapath
Proguanil—DHFR—Pemetrexed—lung cancer	0.351	0.605	CbGbCtD
Proguanil—CYP2E1—lung cancer	0.259	1	CbGaD
Proguanil—DHFR—Methotrexate—lung cancer	0.0595	0.103	CbGbCtD
Proguanil—CYP2C19—Gefitinib—lung cancer	0.014	0.0241	CbGbCtD
Proguanil—CYP2C19—Teniposide—lung cancer	0.0136	0.0234	CbGbCtD
Proguanil—CYP2C9—Gefitinib—lung cancer	0.0116	0.02	CbGbCtD
Proguanil—CYP2C9—Teniposide—lung cancer	0.0113	0.0194	CbGbCtD
Proguanil—CYP2D6—Gefitinib—lung cancer	0.0106	0.0183	CbGbCtD
Proguanil—CYP2E1—Etoposide—lung cancer	0.00954	0.0164	CbGbCtD
Proguanil—CYP2D6—Vinorelbine—lung cancer	0.00818	0.0141	CbGbCtD
Proguanil—CYP1A2—Erlotinib—lung cancer	0.00762	0.0131	CbGbCtD
Proguanil—CYP3A4—Topotecan—lung cancer	0.00739	0.0127	CbGbCtD
Proguanil—CYP3A4—Gefitinib—lung cancer	0.00676	0.0116	CbGbCtD
Proguanil—CYP3A4—Teniposide—lung cancer	0.00655	0.0113	CbGbCtD
Proguanil—CYP2C9—Paclitaxel—lung cancer	0.00629	0.0108	CbGbCtD
Proguanil—CYP2D6—Erlotinib—lung cancer	0.00628	0.0108	CbGbCtD
Proguanil—CYP1A2—Etoposide—lung cancer	0.00551	0.00951	CbGbCtD
Proguanil—CYP3A4—Vinorelbine—lung cancer	0.0052	0.00897	CbGbCtD
Proguanil—CYP2C9—Cisplatin—lung cancer	0.00506	0.00872	CbGbCtD
Proguanil—CYP2D6—Vinblastine—lung cancer	0.00504	0.0087	CbGbCtD
Proguanil—CYP3A4—Crizotinib—lung cancer	0.00414	0.00714	CbGbCtD
Proguanil—CYP3A4—Erlotinib—lung cancer	0.00399	0.00689	CbGbCtD
Proguanil—CYP3A4—Paclitaxel—lung cancer	0.00366	0.00631	CbGbCtD
Proguanil—CYP3A4—Irinotecan—lung cancer	0.00361	0.00622	CbGbCtD
Proguanil—CYP3A4—Vinblastine—lung cancer	0.00321	0.00553	CbGbCtD
Proguanil—CYP2D6—Doxorubicin—lung cancer	0.0031	0.00534	CbGbCtD
Proguanil—CYP3A4—Etoposide—lung cancer	0.00289	0.00498	CbGbCtD
Proguanil—CYP3A4—Docetaxel—lung cancer	0.00264	0.00456	CbGbCtD
Proguanil—CYP3A4—Doxorubicin—lung cancer	0.00197	0.0034	CbGbCtD
Proguanil—Gastrointestinal pain—Teniposide—lung cancer	0.000366	0.00419	CcSEcCtD
Proguanil—Immune system disorder—Vinorelbine—lung cancer	0.00036	0.00413	CcSEcCtD
Proguanil—Mediastinal disorder—Vinorelbine—lung cancer	0.00036	0.00412	CcSEcCtD
Proguanil—Nausea—Crizotinib—lung cancer	0.000359	0.00411	CcSEcCtD
Proguanil—Stomatitis—Irinotecan—lung cancer	0.000357	0.0041	CcSEcCtD
Proguanil—Pancytopenia—Cisplatin—lung cancer	0.000355	0.00406	CcSEcCtD
Proguanil—Cough—Topotecan—lung cancer	0.000354	0.00406	CcSEcCtD
Proguanil—Abdominal pain—Teniposide—lung cancer	0.000354	0.00405	CcSEcCtD
Proguanil—Body temperature increased—Teniposide—lung cancer	0.000354	0.00405	CcSEcCtD
Proguanil—Vomiting—Pemetrexed—lung cancer	0.000351	0.00402	CcSEcCtD
Proguanil—Cough—Erlotinib—lung cancer	0.000351	0.00402	CcSEcCtD
Proguanil—Vomiting—Gefitinib—lung cancer	0.000349	0.004	CcSEcCtD
Proguanil—Stomatitis—Gemcitabine—lung cancer	0.000348	0.00399	CcSEcCtD
Proguanil—Rash—Pemetrexed—lung cancer	0.000348	0.00399	CcSEcCtD
Proguanil—Dermatitis—Pemetrexed—lung cancer	0.000348	0.00399	CcSEcCtD
Proguanil—Erythema—Vinorelbine—lung cancer	0.000347	0.00398	CcSEcCtD
Proguanil—Malnutrition—Vinorelbine—lung cancer	0.000347	0.00398	CcSEcCtD
Proguanil—Rash—Gefitinib—lung cancer	0.000346	0.00396	CcSEcCtD
Proguanil—Dermatitis—Gefitinib—lung cancer	0.000346	0.00396	CcSEcCtD
Proguanil—Hepatic enzyme increased—Methotrexate—lung cancer	0.000345	0.00396	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Topotecan—lung cancer	0.000343	0.00393	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—lung cancer	0.00034	0.00389	CcSEcCtD
Proguanil—Hepatobiliary disease—Gemcitabine—lung cancer	0.000338	0.00387	CcSEcCtD
Proguanil—Nausea—Pemetrexed—lung cancer	0.000328	0.00376	CcSEcCtD
Proguanil—Nausea—Gefitinib—lung cancer	0.000326	0.00373	CcSEcCtD
Proguanil—Anorexia—Vinblastine—lung cancer	0.000325	0.00373	CcSEcCtD
Proguanil—Nervous system disorder—Topotecan—lung cancer	0.000325	0.00372	CcSEcCtD
Proguanil—Pancytopenia—Etoposide—lung cancer	0.000325	0.00372	CcSEcCtD
Proguanil—Stomatitis—Cisplatin—lung cancer	0.000325	0.00372	CcSEcCtD
Proguanil—Skin disorder—Topotecan—lung cancer	0.000322	0.00369	CcSEcCtD
Proguanil—Nervous system disorder—Erlotinib—lung cancer	0.000322	0.00369	CcSEcCtD
Proguanil—Skin disorder—Erlotinib—lung cancer	0.000319	0.00365	CcSEcCtD
Proguanil—Pancytopenia—Paclitaxel—lung cancer	0.000319	0.00365	CcSEcCtD
Proguanil—Anorexia—Topotecan—lung cancer	0.000316	0.00362	CcSEcCtD
Proguanil—Hepatobiliary disease—Cisplatin—lung cancer	0.000315	0.00361	CcSEcCtD
Proguanil—Anorexia—Erlotinib—lung cancer	0.000313	0.00358	CcSEcCtD
Proguanil—Diarrhoea—Teniposide—lung cancer	0.000306	0.00351	CcSEcCtD
Proguanil—Cough—Vinorelbine—lung cancer	0.000303	0.00347	CcSEcCtD
Proguanil—Immune system disorder—Irinotecan—lung cancer	0.000297	0.00341	CcSEcCtD
Proguanil—Stomatitis—Etoposide—lung cancer	0.000297	0.00341	CcSEcCtD
Proguanil—Mediastinal disorder—Irinotecan—lung cancer	0.000297	0.0034	CcSEcCtD
Proguanil—Decreased appetite—Vinblastine—lung cancer	0.000297	0.0034	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.000294	0.00337	CcSEcCtD
Proguanil—Stomatitis—Paclitaxel—lung cancer	0.000291	0.00334	CcSEcCtD
Proguanil—Immune system disorder—Gemcitabine—lung cancer	0.00029	0.00332	CcSEcCtD
Proguanil—Mediastinal disorder—Gemcitabine—lung cancer	0.000289	0.00331	CcSEcCtD
Proguanil—Hepatobiliary disease—Etoposide—lung cancer	0.000288	0.00331	CcSEcCtD
Proguanil—Decreased appetite—Topotecan—lung cancer	0.000288	0.0033	CcSEcCtD
Proguanil—Gastrointestinal disorder—Topotecan—lung cancer	0.000286	0.00328	CcSEcCtD
Proguanil—Decreased appetite—Erlotinib—lung cancer	0.000285	0.00327	CcSEcCtD
Proguanil—Vomiting—Teniposide—lung cancer	0.000284	0.00326	CcSEcCtD
Proguanil—Gastrointestinal disorder—Erlotinib—lung cancer	0.000283	0.00324	CcSEcCtD
Proguanil—Hepatobiliary disease—Paclitaxel—lung cancer	0.000283	0.00324	CcSEcCtD
Proguanil—Rash—Teniposide—lung cancer	0.000282	0.00323	CcSEcCtD
Proguanil—Dermatitis—Teniposide—lung cancer	0.000282	0.00323	CcSEcCtD
Proguanil—Headache—Teniposide—lung cancer	0.00028	0.00321	CcSEcCtD
Proguanil—Erythema—Gemcitabine—lung cancer	0.000279	0.0032	CcSEcCtD
Proguanil—Gastrointestinal pain—Vinblastine—lung cancer	0.000279	0.0032	CcSEcCtD
Proguanil—Nervous system disorder—Vinorelbine—lung cancer	0.000278	0.00319	CcSEcCtD
Proguanil—Skin disorder—Vinorelbine—lung cancer	0.000275	0.00316	CcSEcCtD
Proguanil—Gastrointestinal pain—Topotecan—lung cancer	0.000271	0.00311	CcSEcCtD
Proguanil—Anorexia—Vinorelbine—lung cancer	0.00027	0.0031	CcSEcCtD
Proguanil—Pancytopenia—Docetaxel—lung cancer	0.00027	0.00309	CcSEcCtD
Proguanil—Immune system disorder—Cisplatin—lung cancer	0.00027	0.00309	CcSEcCtD
Proguanil—Abdominal pain—Vinblastine—lung cancer	0.00027	0.00309	CcSEcCtD
Proguanil—Mediastinal disorder—Cisplatin—lung cancer	0.000269	0.00309	CcSEcCtD
Proguanil—Gastrointestinal pain—Erlotinib—lung cancer	0.000268	0.00307	CcSEcCtD
Proguanil—Nausea—Teniposide—lung cancer	0.000266	0.00304	CcSEcCtD
Proguanil—Abdominal pain—Topotecan—lung cancer	0.000262	0.003	CcSEcCtD
Proguanil—Body temperature increased—Topotecan—lung cancer	0.000262	0.003	CcSEcCtD
Proguanil—Erythema—Cisplatin—lung cancer	0.00026	0.00298	CcSEcCtD
Proguanil—Malnutrition—Cisplatin—lung cancer	0.00026	0.00298	CcSEcCtD
Proguanil—Abdominal pain—Erlotinib—lung cancer	0.000259	0.00297	CcSEcCtD
Proguanil—Body temperature increased—Erlotinib—lung cancer	0.000259	0.00297	CcSEcCtD
Proguanil—Cough—Irinotecan—lung cancer	0.00025	0.00286	CcSEcCtD
Proguanil—Immune system disorder—Etoposide—lung cancer	0.000247	0.00283	CcSEcCtD
Proguanil—Stomatitis—Docetaxel—lung cancer	0.000247	0.00283	CcSEcCtD
Proguanil—Mediastinal disorder—Etoposide—lung cancer	0.000247	0.00283	CcSEcCtD
Proguanil—Decreased appetite—Vinorelbine—lung cancer	0.000246	0.00282	CcSEcCtD
Proguanil—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000245	0.0028	CcSEcCtD
Proguanil—Cough—Gemcitabine—lung cancer	0.000244	0.00279	CcSEcCtD
Proguanil—Immune system disorder—Paclitaxel—lung cancer	0.000242	0.00278	CcSEcCtD
Proguanil—Mediastinal disorder—Paclitaxel—lung cancer	0.000242	0.00277	CcSEcCtD
Proguanil—Hepatobiliary disease—Docetaxel—lung cancer	0.00024	0.00275	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000236	0.0027	CcSEcCtD
Proguanil—Mental disorder—Paclitaxel—lung cancer	0.000235	0.00269	CcSEcCtD
Proguanil—Malnutrition—Paclitaxel—lung cancer	0.000234	0.00268	CcSEcCtD
Proguanil—Erythema—Paclitaxel—lung cancer	0.000234	0.00268	CcSEcCtD
Proguanil—Diarrhoea—Vinblastine—lung cancer	0.000233	0.00267	CcSEcCtD
Proguanil—Gastrointestinal pain—Vinorelbine—lung cancer	0.000232	0.00266	CcSEcCtD
Proguanil—Nervous system disorder—Irinotecan—lung cancer	0.000229	0.00263	CcSEcCtD
Proguanil—Diarrhoea—Topotecan—lung cancer	0.000227	0.0026	CcSEcCtD
Proguanil—Diarrhoea—Erlotinib—lung cancer	0.000224	0.00257	CcSEcCtD
Proguanil—Abdominal pain—Vinorelbine—lung cancer	0.000224	0.00257	CcSEcCtD
Proguanil—Body temperature increased—Vinorelbine—lung cancer	0.000224	0.00257	CcSEcCtD
Proguanil—Nervous system disorder—Gemcitabine—lung cancer	0.000223	0.00256	CcSEcCtD
Proguanil—Anorexia—Irinotecan—lung cancer	0.000223	0.00255	CcSEcCtD
Proguanil—Skin disorder—Gemcitabine—lung cancer	0.000221	0.00254	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00022	0.00252	CcSEcCtD
Proguanil—Anorexia—Gemcitabine—lung cancer	0.000217	0.00249	CcSEcCtD
Proguanil—Vomiting—Vinblastine—lung cancer	0.000217	0.00249	CcSEcCtD
Proguanil—Headache—Vinblastine—lung cancer	0.000214	0.00245	CcSEcCtD
Proguanil—Vomiting—Topotecan—lung cancer	0.000211	0.00241	CcSEcCtD
Proguanil—Rash—Topotecan—lung cancer	0.000209	0.00239	CcSEcCtD
Proguanil—Dermatitis—Topotecan—lung cancer	0.000209	0.00239	CcSEcCtD
Proguanil—Vomiting—Erlotinib—lung cancer	0.000209	0.00239	CcSEcCtD
Proguanil—Nervous system disorder—Cisplatin—lung cancer	0.000208	0.00239	CcSEcCtD
Proguanil—Cough—Etoposide—lung cancer	0.000208	0.00238	CcSEcCtD
Proguanil—Headache—Topotecan—lung cancer	0.000208	0.00238	CcSEcCtD
Proguanil—Rash—Erlotinib—lung cancer	0.000207	0.00237	CcSEcCtD
Proguanil—Dermatitis—Erlotinib—lung cancer	0.000207	0.00237	CcSEcCtD
Proguanil—Skin disorder—Cisplatin—lung cancer	0.000206	0.00236	CcSEcCtD
Proguanil—Immune system disorder—Docetaxel—lung cancer	0.000206	0.00235	CcSEcCtD
Proguanil—Headache—Erlotinib—lung cancer	0.000205	0.00235	CcSEcCtD
Proguanil—Mediastinal disorder—Docetaxel—lung cancer	0.000205	0.00235	CcSEcCtD
Proguanil—Cough—Paclitaxel—lung cancer	0.000204	0.00234	CcSEcCtD
Proguanil—Decreased appetite—Irinotecan—lung cancer	0.000203	0.00233	CcSEcCtD
Proguanil—Nausea—Vinblastine—lung cancer	0.000203	0.00232	CcSEcCtD
Proguanil—Anorexia—Cisplatin—lung cancer	0.000202	0.00232	CcSEcCtD
Proguanil—Gastrointestinal disorder—Irinotecan—lung cancer	0.000202	0.00231	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000202	0.00231	CcSEcCtD
Proguanil—Mental disorder—Docetaxel—lung cancer	0.000199	0.00228	CcSEcCtD
Proguanil—Erythema—Docetaxel—lung cancer	0.000198	0.00227	CcSEcCtD
Proguanil—Malnutrition—Docetaxel—lung cancer	0.000198	0.00227	CcSEcCtD
Proguanil—Decreased appetite—Gemcitabine—lung cancer	0.000198	0.00227	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000198	0.00226	CcSEcCtD
Proguanil—Nausea—Topotecan—lung cancer	0.000197	0.00226	CcSEcCtD
Proguanil—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000197	0.00225	CcSEcCtD
Proguanil—Nausea—Erlotinib—lung cancer	0.000195	0.00223	CcSEcCtD
Proguanil—Pancytopenia—Methotrexate—lung cancer	0.000195	0.00223	CcSEcCtD
Proguanil—Diarrhoea—Vinorelbine—lung cancer	0.000194	0.00222	CcSEcCtD
Proguanil—Gastrointestinal pain—Irinotecan—lung cancer	0.000191	0.00219	CcSEcCtD
Proguanil—Skin disorder—Etoposide—lung cancer	0.000189	0.00216	CcSEcCtD
Proguanil—Nervous system disorder—Paclitaxel—lung cancer	0.000187	0.00214	CcSEcCtD
Proguanil—Anorexia—Etoposide—lung cancer	0.000185	0.00212	CcSEcCtD
Proguanil—Skin disorder—Paclitaxel—lung cancer	0.000185	0.00212	CcSEcCtD
Proguanil—Body temperature increased—Irinotecan—lung cancer	0.000185	0.00212	CcSEcCtD
Proguanil—Abdominal pain—Irinotecan—lung cancer	0.000185	0.00212	CcSEcCtD
Proguanil—Decreased appetite—Cisplatin—lung cancer	0.000185	0.00211	CcSEcCtD
Proguanil—Gastrointestinal disorder—Cisplatin—lung cancer	0.000183	0.0021	CcSEcCtD
Proguanil—Anorexia—Paclitaxel—lung cancer	0.000182	0.00208	CcSEcCtD
Proguanil—Vomiting—Vinorelbine—lung cancer	0.00018	0.00207	CcSEcCtD
Proguanil—Body temperature increased—Gemcitabine—lung cancer	0.00018	0.00206	CcSEcCtD
Proguanil—Rash—Vinorelbine—lung cancer	0.000179	0.00205	CcSEcCtD
Proguanil—Dermatitis—Vinorelbine—lung cancer	0.000179	0.00205	CcSEcCtD
Proguanil—Stomatitis—Methotrexate—lung cancer	0.000178	0.00204	CcSEcCtD
Proguanil—Headache—Vinorelbine—lung cancer	0.000178	0.00204	CcSEcCtD
Proguanil—Cough—Docetaxel—lung cancer	0.000173	0.00198	CcSEcCtD
Proguanil—Hepatobiliary disease—Methotrexate—lung cancer	0.000173	0.00198	CcSEcCtD
Proguanil—Decreased appetite—Etoposide—lung cancer	0.000169	0.00194	CcSEcCtD
Proguanil—Pancytopenia—Doxorubicin—lung cancer	0.000168	0.00193	CcSEcCtD
Proguanil—Nausea—Vinorelbine—lung cancer	0.000168	0.00193	CcSEcCtD
Proguanil—Gastrointestinal disorder—Etoposide—lung cancer	0.000168	0.00192	CcSEcCtD
Proguanil—Body temperature increased—Cisplatin—lung cancer	0.000168	0.00192	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000167	0.00192	CcSEcCtD
Proguanil—Decreased appetite—Paclitaxel—lung cancer	0.000166	0.0019	CcSEcCtD
Proguanil—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000165	0.00189	CcSEcCtD
Proguanil—Diarrhoea—Irinotecan—lung cancer	0.00016	0.00183	CcSEcCtD
Proguanil—Gastrointestinal pain—Etoposide—lung cancer	0.000159	0.00182	CcSEcCtD
Proguanil—Nervous system disorder—Docetaxel—lung cancer	0.000159	0.00182	CcSEcCtD
Proguanil—Skin disorder—Docetaxel—lung cancer	0.000157	0.0018	CcSEcCtD
Proguanil—Gastrointestinal pain—Paclitaxel—lung cancer	0.000156	0.00179	CcSEcCtD
Proguanil—Diarrhoea—Gemcitabine—lung cancer	0.000156	0.00179	CcSEcCtD
Proguanil—Stomatitis—Doxorubicin—lung cancer	0.000154	0.00177	CcSEcCtD
Proguanil—Anorexia—Docetaxel—lung cancer	0.000154	0.00177	CcSEcCtD
Proguanil—Abdominal pain—Etoposide—lung cancer	0.000154	0.00176	CcSEcCtD
Proguanil—Body temperature increased—Etoposide—lung cancer	0.000154	0.00176	CcSEcCtD
Proguanil—Body temperature increased—Paclitaxel—lung cancer	0.000151	0.00173	CcSEcCtD
Proguanil—Abdominal pain—Paclitaxel—lung cancer	0.000151	0.00173	CcSEcCtD
Proguanil—Hepatobiliary disease—Doxorubicin—lung cancer	0.00015	0.00171	CcSEcCtD
Proguanil—Vomiting—Irinotecan—lung cancer	0.000149	0.0017	CcSEcCtD
Proguanil—Immune system disorder—Methotrexate—lung cancer	0.000148	0.0017	CcSEcCtD
Proguanil—Mediastinal disorder—Methotrexate—lung cancer	0.000148	0.00169	CcSEcCtD
Proguanil—Rash—Irinotecan—lung cancer	0.000147	0.00169	CcSEcCtD
Proguanil—Dermatitis—Irinotecan—lung cancer	0.000147	0.00169	CcSEcCtD
Proguanil—Headache—Irinotecan—lung cancer	0.000147	0.00168	CcSEcCtD
Proguanil—Diarrhoea—Cisplatin—lung cancer	0.000145	0.00166	CcSEcCtD
Proguanil—Vomiting—Gemcitabine—lung cancer	0.000145	0.00166	CcSEcCtD
Proguanil—Mental disorder—Methotrexate—lung cancer	0.000144	0.00165	CcSEcCtD
Proguanil—Rash—Gemcitabine—lung cancer	0.000144	0.00165	CcSEcCtD
Proguanil—Dermatitis—Gemcitabine—lung cancer	0.000143	0.00164	CcSEcCtD
Proguanil—Malnutrition—Methotrexate—lung cancer	0.000143	0.00164	CcSEcCtD
Proguanil—Erythema—Methotrexate—lung cancer	0.000143	0.00164	CcSEcCtD
Proguanil—Headache—Gemcitabine—lung cancer	0.000143	0.00164	CcSEcCtD
Proguanil—Decreased appetite—Docetaxel—lung cancer	0.000141	0.00161	CcSEcCtD
Proguanil—Gastrointestinal disorder—Docetaxel—lung cancer	0.00014	0.0016	CcSEcCtD
Proguanil—Nausea—Irinotecan—lung cancer	0.000139	0.00159	CcSEcCtD
Proguanil—Nausea—Gemcitabine—lung cancer	0.000135	0.00155	CcSEcCtD
Proguanil—Vomiting—Cisplatin—lung cancer	0.000135	0.00155	CcSEcCtD
Proguanil—Rash—Cisplatin—lung cancer	0.000134	0.00153	CcSEcCtD
Proguanil—Dermatitis—Cisplatin—lung cancer	0.000134	0.00153	CcSEcCtD
Proguanil—Diarrhoea—Etoposide—lung cancer	0.000133	0.00152	CcSEcCtD
Proguanil—Gastrointestinal pain—Docetaxel—lung cancer	0.000132	0.00151	CcSEcCtD
Proguanil—Diarrhoea—Paclitaxel—lung cancer	0.00013	0.0015	CcSEcCtD
Proguanil—Immune system disorder—Doxorubicin—lung cancer	0.000128	0.00147	CcSEcCtD
Proguanil—Mediastinal disorder—Doxorubicin—lung cancer	0.000128	0.00147	CcSEcCtD
Proguanil—Body temperature increased—Docetaxel—lung cancer	0.000128	0.00146	CcSEcCtD
Proguanil—Abdominal pain—Docetaxel—lung cancer	0.000128	0.00146	CcSEcCtD
Proguanil—Nausea—Cisplatin—lung cancer	0.000126	0.00145	CcSEcCtD
Proguanil—Cough—Methotrexate—lung cancer	0.000125	0.00143	CcSEcCtD
Proguanil—Mental disorder—Doxorubicin—lung cancer	0.000124	0.00143	CcSEcCtD
Proguanil—Vomiting—Etoposide—lung cancer	0.000124	0.00142	CcSEcCtD
Proguanil—Erythema—Doxorubicin—lung cancer	0.000124	0.00142	CcSEcCtD
Proguanil—Malnutrition—Doxorubicin—lung cancer	0.000124	0.00142	CcSEcCtD
Proguanil—Rash—Etoposide—lung cancer	0.000123	0.00141	CcSEcCtD
Proguanil—Dermatitis—Etoposide—lung cancer	0.000123	0.0014	CcSEcCtD
Proguanil—Headache—Etoposide—lung cancer	0.000122	0.0014	CcSEcCtD
Proguanil—Vomiting—Paclitaxel—lung cancer	0.000121	0.00139	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000121	0.00138	CcSEcCtD
Proguanil—Rash—Paclitaxel—lung cancer	0.00012	0.00138	CcSEcCtD
Proguanil—Dermatitis—Paclitaxel—lung cancer	0.00012	0.00138	CcSEcCtD
Proguanil—Headache—Paclitaxel—lung cancer	0.000119	0.00137	CcSEcCtD
Proguanil—Nausea—Etoposide—lung cancer	0.000116	0.00132	CcSEcCtD
Proguanil—Nervous system disorder—Methotrexate—lung cancer	0.000114	0.00131	CcSEcCtD
Proguanil—Nausea—Paclitaxel—lung cancer	0.000113	0.0013	CcSEcCtD
Proguanil—Skin disorder—Methotrexate—lung cancer	0.000113	0.0013	CcSEcCtD
Proguanil—Anorexia—Methotrexate—lung cancer	0.000111	0.00127	CcSEcCtD
Proguanil—Diarrhoea—Docetaxel—lung cancer	0.000111	0.00127	CcSEcCtD
Proguanil—Cough—Doxorubicin—lung cancer	0.000108	0.00124	CcSEcCtD
Proguanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000105	0.0012	CcSEcCtD
Proguanil—Vomiting—Docetaxel—lung cancer	0.000103	0.00118	CcSEcCtD
Proguanil—Rash—Docetaxel—lung cancer	0.000102	0.00117	CcSEcCtD
Proguanil—Dermatitis—Docetaxel—lung cancer	0.000102	0.00117	CcSEcCtD
Proguanil—Decreased appetite—Methotrexate—lung cancer	0.000101	0.00116	CcSEcCtD
Proguanil—Headache—Docetaxel—lung cancer	0.000101	0.00116	CcSEcCtD
Proguanil—Gastrointestinal disorder—Methotrexate—lung cancer	0.000101	0.00115	CcSEcCtD
Proguanil—Nervous system disorder—Doxorubicin—lung cancer	9.89e-05	0.00113	CcSEcCtD
Proguanil—Skin disorder—Doxorubicin—lung cancer	9.8e-05	0.00112	CcSEcCtD
Proguanil—Anorexia—Doxorubicin—lung cancer	9.62e-05	0.0011	CcSEcCtD
Proguanil—Nausea—Docetaxel—lung cancer	9.6e-05	0.0011	CcSEcCtD
Proguanil—Gastrointestinal pain—Methotrexate—lung cancer	9.53e-05	0.00109	CcSEcCtD
Proguanil—Body temperature increased—Methotrexate—lung cancer	9.21e-05	0.00106	CcSEcCtD
Proguanil—Abdominal pain—Methotrexate—lung cancer	9.21e-05	0.00106	CcSEcCtD
Proguanil—Decreased appetite—Doxorubicin—lung cancer	8.77e-05	0.001	CcSEcCtD
Proguanil—Gastrointestinal disorder—Doxorubicin—lung cancer	8.71e-05	0.000998	CcSEcCtD
Proguanil—Gastrointestinal pain—Doxorubicin—lung cancer	8.25e-05	0.000945	CcSEcCtD
Proguanil—Abdominal pain—Doxorubicin—lung cancer	7.98e-05	0.000914	CcSEcCtD
Proguanil—Body temperature increased—Doxorubicin—lung cancer	7.98e-05	0.000914	CcSEcCtD
Proguanil—Diarrhoea—Methotrexate—lung cancer	7.97e-05	0.000913	CcSEcCtD
Proguanil—Vomiting—Methotrexate—lung cancer	7.41e-05	0.000849	CcSEcCtD
Proguanil—Rash—Methotrexate—lung cancer	7.35e-05	0.000842	CcSEcCtD
Proguanil—Dermatitis—Methotrexate—lung cancer	7.34e-05	0.000841	CcSEcCtD
Proguanil—Headache—Methotrexate—lung cancer	7.3e-05	0.000836	CcSEcCtD
Proguanil—Nausea—Methotrexate—lung cancer	6.92e-05	0.000793	CcSEcCtD
Proguanil—Diarrhoea—Doxorubicin—lung cancer	6.9e-05	0.000791	CcSEcCtD
Proguanil—Vomiting—Doxorubicin—lung cancer	6.41e-05	0.000735	CcSEcCtD
Proguanil—Rash—Doxorubicin—lung cancer	6.36e-05	0.000729	CcSEcCtD
Proguanil—Dermatitis—Doxorubicin—lung cancer	6.36e-05	0.000728	CcSEcCtD
Proguanil—Headache—Doxorubicin—lung cancer	6.32e-05	0.000724	CcSEcCtD
Proguanil—Nausea—Doxorubicin—lung cancer	5.99e-05	0.000687	CcSEcCtD
Proguanil—DHFR—Disease—EGFR—lung cancer	8.46e-06	0.000114	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—MTMR3—lung cancer	8.45e-06	0.000114	CbGpPWpGaD
Proguanil—DHFR—Metabolism—EP300—lung cancer	8.31e-06	0.000112	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTA4—lung cancer	8.3e-06	0.000112	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NCOA3—lung cancer	8.29e-06	0.000112	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—NQO1—lung cancer	8.27e-06	0.000112	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GNG11—lung cancer	8.25e-06	0.000111	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PGAM1—lung cancer	8.23e-06	0.000111	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GNG11—lung cancer	8.18e-06	0.00011	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.15e-06	0.00011	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.14e-06	0.00011	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	8.11e-06	0.000109	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTA2—lung cancer	8.08e-06	0.000109	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ABCG2—lung cancer	8.07e-06	0.000109	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ADCY1—lung cancer	8.07e-06	0.000109	CbGpPWpGaD
Proguanil—DHFR—Disease—KRAS—lung cancer	7.99e-06	0.000108	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—HPGDS—lung cancer	7.91e-06	0.000107	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ENO2—lung cancer	7.91e-06	0.000107	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PPP2R1B—lung cancer	7.86e-06	0.000106	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALDOA—lung cancer	7.86e-06	0.000106	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2A7—lung cancer	7.85e-06	0.000106	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTA1—lung cancer	7.8e-06	0.000105	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALDOA—lung cancer	7.79e-06	0.000105	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.76e-06	0.000105	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCC3—lung cancer	7.71e-06	0.000104	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—SDC4—lung cancer	7.69e-06	0.000104	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTT1—lung cancer	7.67e-06	0.000104	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NCOA3—lung cancer	7.63e-06	0.000103	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GCLC—lung cancer	7.59e-06	0.000102	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP2A6—lung cancer	7.59e-06	0.000102	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NCOA3—lung cancer	7.56e-06	0.000102	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.56e-06	0.000102	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKR1C1—lung cancer	7.47e-06	0.000101	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—STK11—lung cancer	7.45e-06	0.000101	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.43e-06	0.0001	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCG2—lung cancer	7.42e-06	0.0001	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ADCY1—lung cancer	7.42e-06	0.0001	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ADCY1—lung cancer	7.36e-06	9.93e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCG2—lung cancer	7.36e-06	9.93e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—PIK3CA—lung cancer	7.34e-06	9.91e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—HPGDS—lung cancer	7.28e-06	9.83e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ENO2—lung cancer	7.28e-06	9.83e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—UGT1A1—lung cancer	7.25e-06	9.79e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PPP2R1B—lung cancer	7.23e-06	9.76e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ENO2—lung cancer	7.21e-06	9.74e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—HPGDS—lung cancer	7.21e-06	9.74e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ENO1—lung cancer	7.19e-06	9.71e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PPP2R1B—lung cancer	7.17e-06	9.68e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.17e-06	9.67e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.07e-06	9.55e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.07e-06	9.55e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTT1—lung cancer	7.06e-06	9.53e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA3—lung cancer	7e-06	9.45e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—RRM1—lung cancer	7e-06	9.45e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTT1—lung cancer	7e-06	9.45e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GNG11—lung cancer	6.99e-06	9.44e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GCLC—lung cancer	6.98e-06	9.42e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP2A6—lung cancer	6.98e-06	9.42e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	6.96e-06	9.39e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP2A6—lung cancer	6.92e-06	9.34e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GCLC—lung cancer	6.92e-06	9.34e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTP1—lung cancer	6.89e-06	9.31e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.89e-06	9.3e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—HRAS—lung cancer	6.79e-06	9.17e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CAT—lung cancer	6.71e-06	9.06e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALDOA—lung cancer	6.66e-06	8.99e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ENO1—lung cancer	6.61e-06	8.93e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—B4GALT5—lung cancer	6.58e-06	8.89e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ENO1—lung cancer	6.56e-06	8.85e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.53e-06	8.82e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ABCB1—lung cancer	6.53e-06	8.81e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—IL6—lung cancer	6.5e-06	8.77e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NCOA3—lung cancer	6.46e-06	8.72e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP2E1—lung cancer	6.45e-06	8.71e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.45e-06	8.71e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—TYMS—lung cancer	6.41e-06	8.65e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA4—lung cancer	6.4e-06	8.64e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—NQO1—lung cancer	6.38e-06	8.61e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.35e-06	8.57e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—GSTM1—lung cancer	6.34e-06	8.55e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCG2—lung cancer	6.29e-06	8.49e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ADCY1—lung cancer	6.29e-06	8.49e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.25e-06	8.43e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA2—lung cancer	6.24e-06	8.42e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.19e-06	8.35e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—HPGDS—lung cancer	6.17e-06	8.32e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ENO2—lung cancer	6.17e-06	8.32e-05	CbGpPWpGaD
Proguanil—DHFR—Metabolism—PIK3CA—lung cancer	6.15e-06	8.3e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PPP2R1B—lung cancer	6.13e-06	8.27e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.05e-06	8.16e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTA1—lung cancer	6.02e-06	8.13e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CYP1A1—lung cancer	6.01e-06	8.11e-05	CbGpPWpGaD
Proguanil—DHFR—Disease—AKT1—lung cancer	6e-06	8.09e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTT1—lung cancer	5.98e-06	8.07e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ERCC2—lung cancer	5.96e-06	8.04e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCC3—lung cancer	5.95e-06	8.04e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP2E1—lung cancer	5.93e-06	8.01e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP2A6—lung cancer	5.91e-06	7.98e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GCLC—lung cancer	5.91e-06	7.98e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.89e-06	7.95e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP2E1—lung cancer	5.88e-06	7.94e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—NQO1—lung cancer	5.87e-06	7.92e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—NQO1—lung cancer	5.82e-06	7.85e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKR1C1—lung cancer	5.76e-06	7.78e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—STK11—lung cancer	5.75e-06	7.76e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.69e-06	7.69e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.64e-06	7.62e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ENO1—lung cancer	5.6e-06	7.56e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—UGT1A1—lung cancer	5.6e-06	7.55e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.58e-06	7.54e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.51e-06	7.44e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.4e-06	7.29e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GNG11—lung cancer	5.4e-06	7.28e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTP1—lung cancer	5.32e-06	7.18e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—STK11—lung cancer	5.29e-06	7.14e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—STK11—lung cancer	5.24e-06	7.08e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CAT—lung cancer	5.18e-06	6.99e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—APOA1—lung cancer	5.15e-06	6.96e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.15e-06	6.95e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALDOA—lung cancer	5.14e-06	6.94e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ABCB1—lung cancer	5.04e-06	6.8e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP2E1—lung cancer	5.03e-06	6.79e-05	CbGpPWpGaD
Proguanil—DHFR—Metabolism—AKT1—lung cancer	5.02e-06	6.78e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NCOA3—lung cancer	4.99e-06	6.73e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—NQO1—lung cancer	4.97e-06	6.71e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—TYMS—lung cancer	4.95e-06	6.68e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.92e-06	6.64e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTP1—lung cancer	4.89e-06	6.61e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—GSTM1—lung cancer	4.89e-06	6.6e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.87e-06	6.57e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ADCY1—lung cancer	4.85e-06	6.55e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCG2—lung cancer	4.85e-06	6.55e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTP1—lung cancer	4.85e-06	6.55e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.82e-06	6.51e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CAT—lung cancer	4.76e-06	6.43e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ENO2—lung cancer	4.76e-06	6.42e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—HPGDS—lung cancer	4.76e-06	6.42e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.73e-06	6.38e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CAT—lung cancer	4.72e-06	6.37e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CG—lung cancer	4.7e-06	6.35e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.69e-06	6.34e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CYP1A1—lung cancer	4.63e-06	6.26e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ABCB1—lung cancer	4.63e-06	6.25e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTT1—lung cancer	4.62e-06	6.23e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ERCC2—lung cancer	4.6e-06	6.2e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ABCB1—lung cancer	4.59e-06	6.2e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GCLC—lung cancer	4.56e-06	6.16e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2A6—lung cancer	4.56e-06	6.16e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—TYMS—lung cancer	4.55e-06	6.14e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—TYMS—lung cancer	4.51e-06	6.09e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—GSTM1—lung cancer	4.5e-06	6.07e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—STK11—lung cancer	4.48e-06	6.05e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—POMC—lung cancer	4.48e-06	6.05e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—GSTM1—lung cancer	4.46e-06	6.02e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—CREBBP—lung cancer	4.36e-06	5.89e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ENO1—lung cancer	4.32e-06	5.84e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CYP1A1—lung cancer	4.26e-06	5.75e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ERCC2—lung cancer	4.23e-06	5.71e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CYP1A1—lung cancer	4.23e-06	5.7e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.2e-06	5.68e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ERCC2—lung cancer	4.19e-06	5.66e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTP1—lung cancer	4.14e-06	5.6e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CD—lung cancer	4.14e-06	5.58e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—ALB—lung cancer	4.08e-06	5.51e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CAT—lung cancer	4.03e-06	5.45e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.01e-06	5.41e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—APOA1—lung cancer	3.98e-06	5.37e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ABCB1—lung cancer	3.92e-06	5.3e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP2E1—lung cancer	3.88e-06	5.24e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—TYMS—lung cancer	3.85e-06	5.2e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—NQO1—lung cancer	3.84e-06	5.18e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—GSTM1—lung cancer	3.81e-06	5.14e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.81e-06	5.14e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—APOA1—lung cancer	3.66e-06	4.94e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CG—lung cancer	3.63e-06	4.9e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—APOA1—lung cancer	3.63e-06	4.89e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CYP1A1—lung cancer	3.61e-06	4.87e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CB—lung cancer	3.61e-06	4.87e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ERCC2—lung cancer	3.58e-06	4.83e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTGS2—lung cancer	3.57e-06	4.82e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.47e-06	4.69e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—STK11—lung cancer	3.46e-06	4.67e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—POMC—lung cancer	3.46e-06	4.66e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—CREBBP—lung cancer	3.37e-06	4.54e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CG—lung cancer	3.34e-06	4.51e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CG—lung cancer	3.31e-06	4.47e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTP1—lung cancer	3.2e-06	4.32e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CD—lung cancer	3.19e-06	4.31e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—POMC—lung cancer	3.18e-06	4.29e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—POMC—lung cancer	3.15e-06	4.25e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—ALB—lung cancer	3.15e-06	4.25e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PTEN—lung cancer	3.12e-06	4.21e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CAT—lung cancer	3.11e-06	4.2e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—APOA1—lung cancer	3.1e-06	4.18e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—CREBBP—lung cancer	3.1e-06	4.18e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—CREBBP—lung cancer	3.07e-06	4.14e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ABCB1—lung cancer	3.03e-06	4.09e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—TYMS—lung cancer	2.97e-06	4.01e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—EP300—lung cancer	2.97e-06	4.01e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.97e-06	4e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—GSTM1—lung cancer	2.94e-06	3.97e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CD—lung cancer	2.93e-06	3.96e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CD—lung cancer	2.91e-06	3.93e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—ALB—lung cancer	2.9e-06	3.91e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—ALB—lung cancer	2.87e-06	3.88e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CG—lung cancer	2.83e-06	3.82e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CYP1A1—lung cancer	2.79e-06	3.76e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CB—lung cancer	2.78e-06	3.75e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ERCC2—lung cancer	2.76e-06	3.73e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTGS2—lung cancer	2.76e-06	3.72e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—POMC—lung cancer	2.69e-06	3.63e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—CREBBP—lung cancer	2.62e-06	3.54e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CB—lung cancer	2.56e-06	3.45e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CB—lung cancer	2.54e-06	3.42e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTGS2—lung cancer	2.53e-06	3.42e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTGS2—lung cancer	2.51e-06	3.39e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CD—lung cancer	2.49e-06	3.36e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—ALB—lung cancer	2.45e-06	3.31e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PTEN—lung cancer	2.4e-06	3.24e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—APOA1—lung cancer	2.39e-06	3.23e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—EP300—lung cancer	2.29e-06	3.09e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PTEN—lung cancer	2.21e-06	2.98e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—PIK3CA—lung cancer	2.2e-06	2.97e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PTEN—lung cancer	2.19e-06	2.96e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CG—lung cancer	2.18e-06	2.95e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CB—lung cancer	2.17e-06	2.93e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTGS2—lung cancer	2.15e-06	2.9e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—EP300—lung cancer	2.11e-06	2.85e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—EP300—lung cancer	2.09e-06	2.82e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—POMC—lung cancer	2.08e-06	2.81e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—CREBBP—lung cancer	2.02e-06	2.73e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CD—lung cancer	1.92e-06	2.59e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—ALB—lung cancer	1.89e-06	2.56e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PTEN—lung cancer	1.87e-06	2.53e-05	CbGpPWpGaD
Proguanil—CYP2E1—Metabolism—AKT1—lung cancer	1.8e-06	2.42e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—EP300—lung cancer	1.79e-06	2.41e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—PIK3CA—lung cancer	1.7e-06	2.29e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CB—lung cancer	1.67e-06	2.26e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTGS2—lung cancer	1.66e-06	2.24e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—PIK3CA—lung cancer	1.56e-06	2.11e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—PIK3CA—lung cancer	1.55e-06	2.09e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PTEN—lung cancer	1.45e-06	1.95e-05	CbGpPWpGaD
Proguanil—CYP2C19—Metabolism—AKT1—lung cancer	1.39e-06	1.87e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—EP300—lung cancer	1.38e-06	1.86e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—PIK3CA—lung cancer	1.32e-06	1.78e-05	CbGpPWpGaD
Proguanil—CYP2D6—Metabolism—AKT1—lung cancer	1.27e-06	1.72e-05	CbGpPWpGaD
Proguanil—CYP2C9—Metabolism—AKT1—lung cancer	1.26e-06	1.71e-05	CbGpPWpGaD
Proguanil—CYP1A2—Metabolism—AKT1—lung cancer	1.08e-06	1.46e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—PIK3CA—lung cancer	1.02e-06	1.38e-05	CbGpPWpGaD
Proguanil—CYP3A4—Metabolism—AKT1—lung cancer	8.33e-07	1.12e-05	CbGpPWpGaD
